CTLA4 tagging polymorphisms and risk of colorectal cancer: A case–control study involving 2,306 subjects
OncoTargets and Therapy Aug 13, 2018
Zou C, et al. - Given that the CTLA4 gene has been implicated in the development of colorectal cancer (CRC), researchers examined 1,003 sporadic CRC cases and 1,303 controls in order to study the association between CTLA-4 polymorphisms and CRC risk. For this purpose, they genotyped four CTLA-4 tagging polymorphisms and calculated crude/adjusted ORs with their 95% CIs. They found an increased risk of CRC in relation to the presence of CTLA-4 rs231775 G>A polymorphism. In haplotype comparison analysis, CRC risk was seen to be increased by CTLA-4 Grs3087243Crs16840252 Crs733618 Ars231775, Grs3087243 Crs16840252 Trs733618Ars231775, and other haplotypes. Overall, this study offers evidence for an association of CTLA-4 tagging polymorphisms and haplotypes with CRC risk.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries